Recent Developments: Roche - Acquisition (December 2023): Roche acquired Carmot Therapeutics, adding dual GLP-1/GIP agonist assets to its pipeline, positioning to compete with Novo Nordisk and Eli Lilly in obesity [1]
The copper ion is integral to GHK-Cu's biological activity, serving as a cofactor in enzymatic reactions involved in collagen crosslinking and antioxidant defence mechanisms
During your personalized consultation at Flawless MedSpa, our experienced medical professionals will assess your facial structure and discuss your aesthetic goals to create a customized treatment plan
Research on acetyl tetrapeptide-3 reports a 67% increase in growth activity and a 17% increase in hair diameter in trial populations, with anti-inflammatory effects on the scalp microenvironment cited as a contributing mechanism [1]
IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is a synthetic 83-amino acid analog of human IGF-1 with two key modifications: an arginine substitution at position 3 (replacing glutamic acid) and a 13-amino acid extension peptide at the N-terminus
somerae ZNN-1 decreased significantly ( P 0.05, Fig
